Used in the synthesis of latanoprost, a key ophthalmic medication for treating glaucoma and ocular hypertension. Acts as a protected intermediate during manufacturing, where the tris(triethylsilyl) ether groups shield reactive sites on the molecule, ensuring selective chemical transformations. This protection improves yield and purity in the final active pharmaceutical ingredient. Commonly employed in multi-step organic synthesis under controlled conditions to enable precise functional group manipulation.